SHA:600329 Market Cap

SHA:600329 has a market cap or net worth of 27.13 billion as of April 28, 2026. Its market cap has increased by 30.43% in one year.

Market Cap

27.13B

Enterprise Value

22.87B

Revenue

4.92B

Ranking

n/a

PE Ratio

14.40

Stock Price

39.99

Market Cap Chart

Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 27.13B, an increase of 292.33%. That is a compound annual growth rate of 5.64%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	27.13B	-11.85%
Dec 31, 2025	30.78B	48.69%
Dec 31, 2024	20.70B	-6.43%
Dec 29, 2023	22.12B	21.24%
Dec 30, 2022	18.25B	-6.30%
Dec 31, 2021	19.47B	73.88%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Livzon Pharmaceutical Group	26.50B
Dizal (Jiangsu) Pharmaceutical	26.14B
Shijiazhuang Yiling Pharmaceutical	28.00B
Hubei Jumpcan Pharmaceutical	24.59B
Humanwell Healthcare (Group)	30.34B
Kangmei Pharmaceutical	23.65B
Zhejiang Huahai Pharmaceutical	23.52B
Chengdu Kanghong Pharmaceutical Group	23.31B

Market Cap Rankings